J&J to buy Intra-Cellular Therapies for $14.6B, picking up mental health drug - STAT
J&J said it would buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of large drugmakers’ reentry into neuroscience.
Search Group
Share To
Comments
About Screade
Screade® Inc. version f59620b, copyright 2016 - 2025
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments